Rechovot, Israel

Itzhak Mendel

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 90(Granted Patents)


Location History:

  • Rechovot, IL (2009 - 2015)
  • Rehovot, IL (2017 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Itzhak Mendel: Innovator in Medical Research

Introduction

Itzhak Mendel is a prominent inventor based in Rechovot, Israel, known for his significant contributions to medical research. With a total of 12 patents to his name, Mendel has focused on innovative solutions for treating various diseases, particularly in the fields of inflammation and cancer.

Latest Patents

Mendel's latest patents include groundbreaking work on Motile Sperm Domain containing Protein 2 (MOSPD2). One patent discloses methods for treating, preventing, or reducing the incidence of inflammatory diseases or disorders using inhibitors of MOSPD2. Another patent addresses cancer treatment, detailing methods for reducing the incidence of cancer cell activities and preventing metastasis through the use of MOSPD2 inhibitors. These patents also encompass methods for predicting and diagnosing cancer, highlighting Mendel's commitment to advancing medical science.

Career Highlights

Throughout his career, Itzhak Mendel has worked with notable companies such as Vascular Biogenics Ltd. and Immunewalk Therapeutics, Inc. His work has significantly impacted the development of therapeutic strategies aimed at combating serious health issues.

Collaborations

Mendel has collaborated with esteemed colleagues, including Niva Yacov and Eyal Breitbart, contributing to a rich exchange of ideas and innovations in the medical field.

Conclusion

Itzhak Mendel's innovative work in the realm of medical research, particularly concerning inflammation and cancer, showcases his dedication to improving health outcomes. His patents reflect a deep understanding of complex biological processes and a commitment to developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…